Scarica l'app Stockscreener
16.38
0.24%
-0.04
Dopo l'orario di chiusura:
16.93
0.55
+3.36%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché DYN Giù?
Forum
Previsione
Dyne Therapeutics Inc Borsa (DYN) Ultime notizie
Is Dyne Therapeutics Inc. stock a smart buy before Fed meetingWeekly Stock Recap & Low Risk Entry Point Guides - newser.com
Why Dyne Therapeutics Inc. stock is seen as undervaluedWeekly Profit Report & AI Based Buy and Sell Signals - newser.com
Using RSI to spot recovery in Dyne Therapeutics Inc.Buy Signal & Weekly Setup with ROI Potential - newser.com
Dyne’s Zeleciment Basivarsen Shows Sustained Gains in DM1 Trial at One Year - Insider Monkey
Dyne Therapeutics Inc. (DYN) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
What moving averages say about Dyne Therapeutics Inc.July 2025 PreEarnings & Weekly Breakout Opportunity Watchlist - newser.com
How moving averages guide Dyne Therapeutics Inc. trading2025 Short Interest & Verified Technical Signals - newser.com
Sector ETF performance correlation with Dyne Therapeutics Inc.Quarterly Profit Summary & High Accuracy Swing Trade Signals - newser.com
Will Dyne Therapeutics Inc. stock deliver better than expected guidanceMarket Trend Summary & Daily Profit Maximizing Trade Tips - newser.com
Is Dyne Therapeutics Inc. reversing from oversold territory2025 Winners & Losers & Weekly Return Optimization Alerts - newser.com
What recovery options are there for Dyne Therapeutics Inc.Earnings Miss & Real-Time Sentiment Analysis - newser.com
Will Dyne Therapeutics Inc. stock sustain high P E ratiosTrade Volume Summary & Growth Focused Stock Reports - newser.com
Dyne Therapeutics Inc.’s volatility index tracking explained2025 Stock Rankings & Reliable Trade Execution Plans - newser.com
Analyzing recovery setups for Dyne Therapeutics Inc. investorsVolume Spike & Weekly High Momentum Picks - newser.com
Is Dyne Therapeutics Inc. stock gaining market shareJuly 2025 Fed Impact & Free Community Supported Trade Ideas - newser.com
Does Dyne Therapeutics Inc. fit your quant trading modelWeekly Trend Report & AI Powered Market Entry Strategies - newser.com
Dyne Therapeutics (NASDAQ:DYN) Shares Gap Down After Analyst Downgrade - MarketBeat
Oppenheimer Downgrades Dyne Therapeutics (NASDAQ:DYN) to Market Perform - MarketBeat
Dyne Therapeutics (DYN) Sees Downgrade by Oppenheimer | DYN Stoc - GuruFocus
Dyne Therapeutics (DYN) Is Up 17.0% After Positive One-Year ACHIEVE Trial Data for Z-Basivarsen – Has The Bull Case Changed? - Yahoo Finance
Heatmap analysis for Dyne Therapeutics Inc. and competitorsJuly 2025 Weekly Recap & Reliable Volume Spike Trade Alerts - newser.com
Signal strength of Dyne Therapeutics Inc. stock in tech scannersMarket Volume Summary & Stock Portfolio Risk Management - newser.com
Will Dyne Therapeutics Inc. stock keep outperforming rivalsMarket Weekly Review & Daily Growth Stock Investment Tips - newser.com
Can Dyne Therapeutics Inc. stock hit analyst price targets2025 Historical Comparison & Advanced Swing Trade Entry Plans - newser.com
Weiss Ratings Reaffirms Sell (D-) Rating for Dyne Therapeutics (NASDAQ:DYN) - MarketBeat
What machine learning models say about Dyne Therapeutics Inc.2025 Technical Overview & Low Volatility Stock Recommendations - newser.com
Dyne: Accelerated Approval Established Endpoint Sets Stage For DM1 Data In Mid-2026 - Seeking Alpha
Dyne Therapeutics Skyrockets on Breakthrough Data – Inside the Surge, Financials & 2026 Catalysts - ts2.tech
Dyne Therapeutics (NASDAQ:DYN) Trading Up 10.8%Here's Why - MarketBeat
Dyne Therapeutics rises on positive data from myotonic dystrophy trial - Seeking Alpha
Dyne Therapeutics (DYN) Reports Encouraging Phase 1/2 Trial Resu - GuruFocus
Dyne Therapeutics Reports Strength, Function Improvement From Myotonic Dystrophy Drug Candidate in Ongoing Early Phase Trial - MarketScreener
1.84%
0.50%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):